Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -0.27%2.02B | 18.18%1.67B | 18.45%1.1B | 9.88%556.69M | -2.23%2.03B | -6.12%1.41B | -7.36%929.7M | -9.16%506.63M | 3.44%2.07B | -1.64%1.5B |
Refunds of taxes and levies | -16.31%7.18M | 295.93%26.62M | 423.75%24.64M | -45.97%1.77M | 23.84%8.57M | 34.06%6.72M | 42.74%4.7M | 81.15%3.27M | 28.36%6.92M | 7.28%5.02M |
Cash received relating to other operating activities | -33.17%6.36M | -60.52%2.8M | -44.18%2.51M | 5.93%1.32M | 27.80%9.51M | 28.64%7.1M | 25.03%4.49M | -31.37%1.24M | -41.45%7.44M | 18.17%5.52M |
Cash inflows from operating activities | -0.49%2.03B | 19.10%1.7B | 20.18%1.13B | 9.51%559.77M | -2.03%2.04B | -5.86%1.42B | -7.08%938.9M | -8.94%511.14M | 3.22%2.09B | -1.56%1.51B |
Goods services cash paid | -7.35%1.12B | 21.21%1.05B | 30.89%698.65M | 18.04%327.73M | -10.67%1.21B | -13.41%862.37M | -19.60%533.77M | -20.30%277.65M | 12.69%1.36B | 3.59%995.89M |
Staff behalf paid | 26.69%493.95M | 23.05%341.94M | 25.24%235.3M | 24.94%128.6M | 6.79%389.9M | 2.21%277.88M | 3.11%187.88M | -4.45%102.93M | 0.44%365.12M | 3.92%271.88M |
All taxes paid | 8.27%118.8M | -4.09%92.62M | -6.77%61.74M | 19.62%26.63M | 14.18%109.72M | 28.62%96.57M | 18.39%66.22M | -21.76%22.26M | -27.20%96.1M | -29.67%75.08M |
Cash paid relating to other operating activities | 19.40%203.13M | -31.78%87.28M | -17.09%65.99M | 22.42%55.36M | 11.33%170.13M | 11.69%127.94M | 0.80%79.6M | -11.62%45.22M | -16.90%152.82M | -21.03%114.55M |
Cash outflows from operating activities | 3.03%1.94B | 14.83%1.57B | 22.39%1.06B | 20.14%538.33M | -4.52%1.88B | -6.36%1.36B | -11.57%867.47M | -16.36%448.07M | 4.64%1.97B | -1.18%1.46B |
Net cash flows from operating activities | -41.41%95.03M | 118.47%128.16M | -6.68%66.65M | -66.00%21.44M | 40.44%162.18M | 7.54%58.66M | 142.38%71.42M | 146.47%63.07M | -16.18%115.48M | -10.60%54.55M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | ---- | ---- | ---- | ---- | -87.37%524.3K | ---- | ---- | ---- | --4.15M | --4.15M |
Cash received from returns on investments | --8.4K | --4.2K | --4.2K | --4.2K | ---- | ---- | ---- | ---- | 0.00%74.2K | 0.00%70K |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -56.47%681.37K | -89.93%141K | 787.20%133.08K | ---- | 110.15%1.57M | 491.47%1.4M | -93.05%15K | ---- | -89.69%744.9K | 161.95%236.81K |
Cash inflows from investing activities | -66.99%689.77K | -89.63%145.2K | 815.20%137.28K | --4.2K | -57.95%2.09M | -68.57%1.4M | -99.66%15K | ---- | -31.92%4.97M | 2,678.56%4.46M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -44.61%90.19M | -1.10%70.94M | -6.22%46.82M | -5.66%33.32M | 16.58%162.82M | 27.31%71.73M | 26.82%49.93M | 75.49%35.32M | 50.16%139.67M | 68.12%56.34M |
Cash outflows from investing activities | -44.61%90.19M | -1.10%70.94M | -6.22%46.82M | -5.66%33.32M | 16.58%162.82M | 27.31%71.73M | 26.82%49.93M | 75.49%35.32M | 50.16%139.67M | 68.12%56.34M |
Net cash flows from investing activities | 44.31%-89.5M | -0.66%-70.8M | 6.47%-46.68M | 5.68%-33.32M | -19.33%-160.73M | -35.55%-70.33M | -42.89%-49.91M | -109.43%-35.32M | -57.15%-134.7M | -55.57%-51.89M |
Financing cash flow | ||||||||||
Cash from borrowing | 1.69%385.81M | 13.08%242M | -26.47%125M | -14.29%30M | -21.06%379.4M | -37.79%214M | -39.29%170M | -30.00%35M | 101.09%480.6M | 129.33%344M |
Cash inflows from financing activities | 1.69%385.81M | 13.08%242M | -26.47%125M | -14.29%30M | -21.06%379.4M | -37.79%214M | -39.29%170M | -30.00%35M | 101.09%480.6M | 129.33%344M |
Borrowing repayment | -11.31%334.25M | 2.35%223.75M | -30.27%108.5M | -42.86%20M | -11.98%376.85M | -28.09%218.6M | -37.76%155.6M | -36.36%35M | 55.40%428.14M | 58.75%304M |
Dividend interest payment | 67.18%42.83M | 28.03%28.42M | 8.78%21.62M | -22.07%2.56M | -25.45%25.62M | -27.77%22.2M | -25.86%19.88M | 9.38%3.29M | -3.28%34.37M | -3.38%30.74M |
-Including:Cash payments for dividends or profit to minority shareholders | 139.85%5.37M | 169.57%4.83M | -18.64%1.46M | ---- | -68.20%2.24M | -72.58%1.79M | -68.20%1.79M | ---- | 282.92%7.04M | 383.75%6.53M |
Cash payments relating to other financing activities | 12.76%3.16M | -11.77%1.56M | -37.00%996.7K | ---- | -10.04%2.8M | -22.96%1.76M | -22.39%1.58M | ---- | 6.16%3.11M | --2.29M |
Cash outflows from financing activities | -6.18%380.24M | 4.60%253.73M | -25.95%131.12M | -41.07%22.56M | -12.96%405.27M | -28.03%242.56M | -36.50%177.06M | -33.99%38.29M | 48.30%465.62M | 50.92%337.03M |
Net cash flows from financing activities | 121.54%5.57M | 58.95%-11.73M | 13.35%-6.12M | 326.05%7.44M | -272.72%-25.87M | -509.68%-28.56M | -714.52%-7.06M | 58.92%-3.29M | 119.98%14.98M | 109.51%6.97M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -122.19%-293.92K | 231.61%2.48M | 189.63%1.46M | 523.56%298.96K | -39.70%1.32M | -34.48%747.44K | -27.01%503.91K | 52.58%-70.58K | 380.82%2.2M | 779.19%1.14M |
Net increase in cash and cash equivalents | 146.79%10.81M | 221.86%48.12M | 2.37%15.31M | -116.98%-4.14M | -1,032.92%-23.09M | -466.40%-39.49M | 512.55%14.96M | 4,206.68%24.39M | 91.39%-2.04M | 123.52%10.78M |
Add:Begin period cash and cash equivalents | -16.58%116.21M | -16.58%116.21M | -16.58%116.21M | -16.58%116.21M | -1.44%139.3M | -1.44%139.3M | -1.44%139.3M | -1.44%139.3M | -14.35%141.34M | -14.09%141.34M |
End period cash equivalent | 9.30%127.01M | 64.63%164.33M | -14.74%131.52M | -31.54%112.07M | -16.58%116.21M | -34.38%99.82M | 12.01%154.26M | 15.35%163.69M | -1.44%139.3M | 28.16%152.12M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.